In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier. (2019)

First Author: Bevan-Jones WR
Attributed to:  A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/acn3.683

PubMed Identifier: 30847369

Publication URI: http://europepmc.org/abstract/MED/30847369

Type: Journal Article/Review

Volume: 6

Parent Publication: Annals of clinical and translational neurology

Issue: 2

ISSN: 2328-9503